Psoriatic disease (PsD) patients show a high prevalence of metabolic liver conditions (44% with MASLD and 22% with MASH) despite normal blood tests. Rates exceed those in matched controls and occur regardless of methotrexate use, highlighting the need for routine liver screening in PsD management e.g. by multiparametric MRI